Researchers at Indiana University and the Regenstrief Institute are measuring whether a virtual walk on the beach could help prevent cognitive issues faced by patients who spend time on a mechanical ventilation machine in the intensive care unit.
The money is designed to further the work of Dr. Burcin Ekser and his team, who are working to print three-dimensional pig liver tissue from genetically engineered pig liver cells.
City leaders want to make the 60-acre tract of land just north of the Indiana University School of Medicine campus a mix of all of the best the city has to offer and catch the eyes of more creative and highly sought-after workers.
Daniel Evans Jr. plans to leave his post as president immediately and retire as CEO on May 1. The system’s chief operating officer, Dennis Murphy, will take over as president now and as CEO in the spring.
Hospitals around the state have been trying to cut emergency room visits—and Obamacare was supposed to help. But the results have been mixed, according to some local hospitals.
In the past two years, IU Health has laid off 935 people, halted construction of a major bed tower, sold off health clinics and decided to close its proton-therapy center. But there are three more years of changes to come, said CFO Ryan Kitchell.
The site of the former Wishard Memorial Hospital could become home to a new combined downtown hospital for Indiana University Health.
Gene Biccard Glick, who died at home following a long battle with Alzheimer’s disease, built affordable housing sprawling across 10 states—a business empire that paved the way for tens of millions of dollars in donations to causes ranging from medicine to recreation.
Sam Odle, one of Indianapolis’ most prominent black business leaders, will be replaced on an interim basis by Jim Terwilliger while the hospital system conducts a national search for his successor.
As St. Vincent Health has nearly doubled the number of physicians it employs over the past two years, the losses on those practices have mounted. And the same thing is happening at all the major Indianapolis hospital systems, as all have spent the past four years aggressively acquiring physician practices.
A new study says biomedical research at the Indiana University School of Medicine and its partner hospitals pumped about $370 million into Indiana's economy in 2009.
The Indiana University School of Medicine has licensed a pediatric psychiatrist’s patent on
an alcohol-dependency drug that the doctor discovered improves the language and social skills of autism patients. IU has licensed the patent to Indianapolis-based Confluence Pharmaceuticals Inc.